BRIDGE-DS study: evaluating the effectiveness and safety of dapagliflozin/sitagliptin combination in type 2 diabetes mellitus patients with heart failure.
Kumar KPNS, Variam MT, S BV, Nath K, Goyal KK, Beswal G, Arun P, Narayan K, Kumar SPS, Ravindranath V, Tripathy N, Kalra BK, Ray P, Garg P, Laul A, Dhand S, Kamat S, Kesarkar RN, Prasad A, Pednekar A.
Kumar KPNS, et al. Among authors: kumar sps.
Cardiovasc Endocrinol Metab. 2025 Sep 3;14(4):e00334. doi: 10.1097/XCE.0000000000000334. eCollection 2025 Dec.
Cardiovasc Endocrinol Metab. 2025.
PMID: 40917544
Free PMC article.